Andrew Sale - Invuity Senior Vice President of Global Sales

President

Mr. Andrew Sale is Senior Vice President of Global Sales of the Company, since January of 2017. Prior to joining us, Mr. Sale served as Vice President at Alpha Genomix Laboratories from August 2015 to June 2016. From April 2004 to December 2014, Mr. Sale served in a variety of roles at Intuitive Surgical, a publicly traded manufacturer of robotic surgical systems, including Sales Manager, Sales Director, Area Vice President, Regional Vice President and in his last role was responsible for all the U.S. capital business. Prior to Intuitive Surgical, Mr. Sale spent six years at Johnson Johnson, where he provided sales and sales leadership in key specialty companies inside of Ethicon to drive the growth of emerging products since 2017.
Age 44
Tenure 7 years
Phone415-665-2100
Webhttp://www.invuity.com
Sale received a B.A. in General Studies from Louisiana State University.

Invuity Management Efficiency

The company has return on total asset (ROA) of (39.66) % which means that it has lost $39.66 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (481.4) %, meaning that it created substantial loss on money invested by shareholders. Invuity's management efficiency ratios could be used to measure how well Invuity manages its routine affairs as well as how well it operates its assets and liabilities.
The company currently holds 34.66 M in liabilities. Invuity has a current ratio of 2.09, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist Invuity until it has trouble settling it off, either with new capital or with free cash flow. So, Invuity's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Invuity sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Invuity to invest in growth at high rates of return. When we think about Invuity's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

PRESIDENT Age

Shannon RileyAmbipar Emergency Response
52
Cynthia PattonAmgen Inc
56
John CruesRadNet Inc
67
Lori JohnstonAmgen Inc
53
Dennys MaioAmbipar Emergency Response
44
Derek BomarRadNet Inc
46
Sean HarperAmgen Inc
54
Todd SkulteRadNet Inc
55
David PiacquadAmgen Inc
61
Jonathan GrahamAmgen Inc
63
Stuart TrossAmgen Inc
48
Pablo ChateauAmbipar Emergency Response
52
Murdo GordonAmgen Inc
57
Esteban SantosAmgen Inc
56
Martin LehaneAmbipar Emergency Response
51
Mital PatelRadNet Inc
38
Brian McNameeAmgen Inc
59
Michael MurdockRadNet Inc
62
David ReeseAmgen Inc
55
Invuity, Inc., a medical technology company, develops and markets surgical devices in the United States and Asia. Invuity, Inc. was incorporated in 2004 and is based in San Francisco, California. Invuity operates under Medical Instruments Supplies classification in USA and is traded on NASDAQ General Markets. It employs 161 people. Invuity (IVTY) is traded on NASDAQ Exchange in USA and employs 161 people.

Management Performance

Invuity Leadership Team

Elected by the shareholders, the Invuity's board of directors comprises two types of representatives: Invuity inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Invuity. The board's role is to monitor Invuity's management team and ensure that shareholders' interests are well served. Invuity's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Invuity's outside directors are responsible for providing unbiased perspectives on the board's policies.
Robert Gerberich, Vice President - Sales and Marketing
Douglas Heigel, VP of Operations
Daniel Wolterman, Director
Alex Vayser, Co-Founder and CTO
William Burke, Independent Director
Philip Sawyer, CEO and President and Director
Eric Roberts, Independent Director
Andrew Sale, Senior Vice President of Global Sales
Scott Flora, Director
Gregory Brown,
James Mackaness, CFO
Steve Annen, Vice President of Product Management and Strategy
Joseph Guido, Vice President of Business Development
Randall Lipps, Independent Director
Paul Davison, VP of RandD
Reza Zadno, Independent Director
Brett Robertson, Chief Business Officer, General Counsel
Gregory Lucier, Chairman of the Board
Marcia Fish, Chief Human Resource Officer

Invuity Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Invuity a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate.
You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.

Other Consideration for investing in Invuity Stock

If you are still planning to invest in Invuity check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Invuity's history and understand the potential risks before investing.
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules